{"disease":{"id":"psoriasis-patients","name":"psoriasis patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05961605","title":"COVID-19 Associated With Psoriasis","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Gang Wang, MD","has_results":false},{"nct_id":"NCT06299982","title":"An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":750,"lead_sponsor_name":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT05381402","title":"Impact of COVID 19 on Psoriasis Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":230,"lead_sponsor_name":"Cairo University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}